Hims & Hers narrows 2026 revenue forecast as margins contract

Nov 9 (Reuters) - Hims & Hers Health (HIMS.N), opens new tab on Monday narrowed its annual revenue forecast to a range below Wall Street estimates as gross ⁠margins contracted amid its expansion into branded weight-loss drugs and international markets.

The company now expects 2026 revenue of $3.13 ⁠billion to $3.15 billion, compared with its previous forecast of $3.1 ⁠billion to $3.3 billion. Analysts expect $3.21 billion, according ⁠to data compiled by LSEG.

Reporting ⁠by Kunal Das in Bengaluru; Editing by Sahal Muhammed